News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Professor Mel Greaves wins Cancer Research UK Lifetime Achievement Award
The ICR’s Professor Mel Greaves has been awarded the Cancer Research UK Lifetime Achievement Award for his work investigating the causes and clonal evolution of childhood leukaemia.
Landmark clinical trial shows gene-targeted drug can treat prostate cancer
First trial to show benefit of ‘precision medicine’ in prostate cancer
Genetic testing could identify men at a 10-fold increased risk of testicular cancer
A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.
Chemical probe to dissect role of potential cancer-causing proteins
Scientists have created a highly specific chemical probe to shed new light on the role two important proteins play in driving cancer cell proliferation.
T-VEC becomes first viral immunotherapy recommended for approval in Europe
A viral immunotherapy for cancer has become the first to be given the green light by European regulators.
Study identifies new treatment target in BRCA2-mutant prostate cancer
Genetic abnormalities associated with poor prognosis in prostate cancer are particularly common in men with germline mutations in the BRCA2 gene.
Test could predict whether breast cancer will spread to the brain
Women with particularly aggressive forms of breast cancer could be identified by a test that predicts whether the disease is likely to spread to the brain.
Another successful year for the ICR team at the Royal Parks Half Marathon
All 24 of our runners in the Royal Parks Half Marathon completed the 13.1 mile course and together are set to raise £25,000 for our research.
ICR scientists set to conquer Mount Snowdon for research into rare teenage cancer
A team of scientists from The Institute of Cancer Research, London, are embarking on a series of fundraising challenges in support of two parent-led charities committed to funding the ICR’s research into teenage cancer.
New test to predict relapse of testicular cancer
Assessing just three features of a common kind of testicular cancer can identify those at most at risk of relapse.
.jpg?sfvrsn=5ee5f73f_2 "Breast epithelial cells under ER stress (Chris Bakal, 2014)")
Blood test could match cancer patients to best treatments
Scientists have developed a blood test that could match cancer patients with the most suitable therapy and track the tumour’s progress to see if the treatment is working.
New test could help personalise treatment for common childhood cancer
A new test that examines the activity of only five genes can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma.
